| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b172e4dc6f8b115773eb99a04e8260f6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
1995-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68f49eb20c3d43cf00eac55abe59a7af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf7b5bf68c06774006cda45ecde2452e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6892ef8f532e997bf0636938e3929861 |
| publicationDate |
1999-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5888545-A |
| titleOfInvention |
Carbamazepine medicament with retarded active substance release |
| abstract |
An oral administration carbamazepine medicament with a retarded active substance release is disclosed. An aqueous plasticised polymer dispersion is applied on carbamazepine crystals without causing formation of carbamazepine dihydrate. The carbamazepine crystals with their aqueous coating may be mixed with appropriate auxiliarly substances, shaped into divisible tablets or filled into capsules. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011033537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007160960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-91270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8414919-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006275367-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011027370-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8795723-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011015205-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011021535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105997916-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007128269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9439866-B2 |
| priorityDate |
1994-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |